GHRP-2

Shop GHRP-2
Code ths10 applied at checkout

Also called: KP-102, Pralmorelin, Pralmorelin Hydrochloride

By The Health Stacks Research TeamUpdated September 23, 2026

GHRP-2 is a man-made chain of tiny building blocks called amino acids. It is a lab-made copy of a natural body signal called ghrelin. Ghrelin is the hormone that makes you feel hungry. GHRP-2 tells a part of the brain to release more growth hormone. Growth hormone is a body chemical that helps with growing, healing, and burning fat.

Scientists have studied GHRP-2 mostly in labs and in animal tests. It works by fitting into the same switches on cells that hunger hormones use. When it turns those switches on, the body releases a burst of growth hormone. Some people in fitness and bodybuilding groups have used it, hoping it would help build muscle or burn fat. Some also said it made them feel very hungry.

There are big problems to know about. GHRP-2 is not an approved medicine anywhere. The US food and drug agency put it in a group of substances that may have serious safety risks, including reported deaths. It is not legal for pharmacies to mix it into medicines. Products sold online are not checked for purity, so you cannot be sure what is in them. Scientists still do not know if it is safe for people, so doctors warn against using it.

Research-stageEarly-stage — evidence so far is mostly cell, animal, or preliminary human studies. Not an approved medicine. High confidence60–79 — backed by solid sources with good corroboration across multiple citations.

Benefits

What GHRP-2 Helps With

The main themes across 23 research studies, in plain language.

Musculoskeletal

Muscle growth & performance

55/100Rated 55/100Source typeEstablished referenceIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 18 underlying claims

Studies indicate potential benefits for increasing muscle mass, strength, and exercise recovery through anabolic pathways.

Research examplesBest source ↗

Bone density & skeletal health

80/100Rated 80/100Source typePeer-reviewed studyIndependent sources4Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 5 underlying claims

Research points to potential improvements in bone density and skeletal growth, particularly in deficient states.

Research examplesBest source ↗

Reproductive & hormonal

Growth hormone release

65/100Rated 65/100Source typeEstablished referenceIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 28 underlying claims

Research suggests GHRP-2 acts as a potent stimulator of growth hormone secretion, often used in diagnostic settings.

Research examplesBest source ↗

Synergy with GHRH analogs

60/100Rated 60/100Source typeSpecialist communityIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 6 underlying claims

Evidence indicates that combining this peptide with GHRH analogs creates a synergistic effect, amplifying growth hormone release.

Research examplesBest source ↗

Hormonal profile & cortisol

60/100Rated 60/100Source typeSpecialist communityIndependent sources4Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 5 underlying claims

Studies suggest a favorable secondary hormone profile compared to similar peptides, with moderate effects on cortisol.

Research examplesBest source ↗

Tissue repair & skin health

40/100Rated 40/100Source typeVendor / seller pageIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 7 underlying claims

Research suggests the peptide may accelerate wound healing and improve skin quality through collagen synthesis.

Research examplesBest source ↗

Anti-inflammatory & organ protection

50/100Rated 50/100Source typeUnclassified sourceIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 7 underlying claims

Studies demonstrate anti-inflammatory actions that may protect organs like the liver and the immune system during stress.

Research examplesBest source ↗

Cellular defense & oxidative stress

60/100Rated 60/100Source typeSpecialist communityIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 6 underlying claims

Findings suggest the compound supports cellular defense mechanisms by suppressing oxidative stress and inhibiting cell death.

Research examplesBest source ↗

Appetite & weight regulation

40/100Rated 40/100Source typeVendor / seller pageIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 13 underlying claims

Research points to appetite-stimulating effects that may increase caloric intake and support weight gain in specific conditions.

Research examplesBest source ↗

Fat metabolism & body composition

40/100Rated 40/100Source typeVendor / seller pageIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 9 underlying claims

Findings imply a role in promoting fat loss and improving overall body composition by reducing fat mass.

Research examplesBest source ↗

Cardiovascular protection

50/100Rated 50/100Source typeUnclassified sourceIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 9 underlying claims

Animal studies indicate potential cardioprotective properties, including the reduction of heart fibrosis and oxidative stress.

Research examplesBest source ↗

Neuroprotection & cognition

72/100Rated 72/100Source typeEstablished referenceIndependent sources4Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 7 underlying claims

Preliminary research suggests neuroprotective effects that may improve memory and reduce markers of brain inflammation.

Research examplesBest source ↗

Sleep quality & architecture

50/100Rated 50/100Source typeUnclassified sourceIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 9 underlying claims

Evidence suggests the compound may enhance sleep depth and quality, particularly slow-wave sleep stages.

Research examplesBest source ↗

Energy & mitochondrial support

30/100Rated 30/100Source typeVendor / seller pageIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 2 underlying claims

Research suggests the peptide may help increase overall energy levels and combat fatigue.

Research examplesBest source ↗

Injury recovery & joint comfort

50/100Rated 50/100Source typeSpecialist communityIndependent sources2Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 4 underlying claims

Anecdotal and preliminary evidence suggest it may accelerate recovery from injuries and improve joint comfort.

Research examplesBest source ↗

Free: The Peptide Stack Cheat-Sheet

You just read the research on GHRP-2. The cheat-sheet maps the most-used peptide stacks — doses, timing, and what to check before buying — on one page.

No spam. Unsubscribe anytime.

How People Use It

1 reported routine — each line links to the source it came from.

From published sources

Routines as reported in peer-reviewed papers, clinical guidance, or vetted media — each linked to the source it came from.

SubQ

  • Not specified (determined by professional) 60/100Rated 60/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source

mg vs mcg: one milligram (mg) equals 1,000 micrograms (mcg) — multiply by 1,000 going from mg to mcg, divide by 1,000 going from mcg to mg. Mixing the two up is a thousand-fold dosing error: 1 mg taken instead of 1 mcg is a 1,000× overdose; 1 mcg instead of 1 mg is a 1,000× underdose. Always double-check the unit label and the decimal place.

Safety

Known Side Effects

Adverse effects reported in the research and by community use.

  • Cardiac arrhythmias and hypokalemia (cesium chloride)LifeThreatening 95/100Rated 95/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ fda.gov
  • Congestive heart failure (ibutamoren mesylate)Severe 92/100Rated 92/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ fda.gov
  • Cesium chloride heart toxicity and arrhythmiasLifeThreatening 90/100Rated 90/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ fda.gov
  • Cesium chloride hypokalemiaModerate 90/100Rated 90/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ fda.gov
  • Chloral hydrate oversedationSevere 90/100Rated 90/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ fda.gov
  • Diethylstilbestrol-associated cancerLifeThreatening 90/100Rated 90/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ fda.gov
  • Domperidone cardiac arrhythmias and sudden cardiac deathLifeThreatening 90/100Rated 90/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ fda.gov
  • Edetate disodium fatal medication errorsLifeThreatening 90/100Rated 90/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ fda.gov
  • Germanium sesquioxide nephrotoxicityLifeThreatening 90/100Rated 90/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ fda.gov
  • GHRP-2 increased insulin requirementModerate 90/100Rated 90/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ fda.gov
  • Ibutamoren mesylate congestive heart failure signalLifeThreatening 90/100Rated 90/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ fda.gov
  • Neomycin sulfate nephrotoxicity and ototoxicityLifeThreatening 90/100Rated 90/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ fda.gov
  • Quinacrine hydrochloride aplastic anemia and hepatitisSevere 90/100Rated 90/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ fda.gov
  • Quinacrine reproductive tract malignanciesLifeThreatening 90/100Rated 90/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ fda.gov
  • Tranilast liver injurySevere 90/100Rated 90/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ fda.gov
  • Tranilast hematologic abnormalitiesSevere 90/100Rated 90/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ fda.gov
  • Tranilast renal failureLifeThreatening 90/100Rated 90/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ fda.gov
  • Elevated liver enzymes, hematologic abnormalities and renal failure (tranilast)LifeThreatening 90/100Rated 90/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ fda.gov
  • GHRP-2 infection and pancreatitisSevere 85/100Rated 85/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ fda.gov
  • Increased insulin requirement, death of critically ill subjects, infection and pancreatitis (GHRP-2)LifeThreatening 85/100Rated 85/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ fda.gov
  • Injection site reactions (painMild 60/100Rated 60/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ synapse.patsnap.com
  • Transient headachesMild 60/100Rated 60/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ synapse.patsnap.com
  • Water retentionSevereReported in 5 sources 60/100Rated 60/100Source typeEstablished referenceIndependent sources5Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ synapse.patsnap.com↗ thepeptidecatalog.com↗ thepeptidecatalog.com↗ thepeptidecatalog.com+1
  • Increased risk of carpal tunnel syndromeSevere 60/100Rated 60/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ synapse.patsnap.com
  • Hyperglycemia or impaired glucose toleranceSevere 60/100Rated 60/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ synapse.patsnap.com
  • RednessMild 60/100Rated 60/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ synapse.patsnap.com
  • DizzinessMild 60/100Rated 60/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ synapse.patsnap.com
  • or nauseaMild 60/100Rated 60/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ synapse.patsnap.com
  • EdemaSevere 60/100Rated 60/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ synapse.patsnap.com
  • swelling)Mild 60/100Rated 60/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ synapse.patsnap.com
  • Flushing and warmth at the injection site or faceMild 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ peptidepedia.org
  • Transient drowsiness or sleepinessMild 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ peptidepedia.org
  • Mild water retention and peripheral edemaMildReported in 2 sources 60/100Rated 60/100Source typeSpecialist communityIndependent sources2Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ peptidepedia.org↗ peptidepedia.org
  • Increased gastrointestinal motilityMildReported in 2 sources 60/100Rated 60/100Source typeSpecialist communityIndependent sources2Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ peptidepedia.org↗ peptidepedia.org
  • Elevations in cortisol and ACTHModerate 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ peptidepedia.org
  • Mild prolactin elevationModerate 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ peptidepedia.org
  • Numbness or tingling in extremitiesMildReported in 2 sources 60/100Rated 60/100Source typeSpecialist communityIndependent sources2Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ peptidepedia.org↗ peptidepedia.org
  • Joint stiffnessMildReported in 2 sources 60/100Rated 60/100Source typeSpecialist communityIndependent sources2Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ peptidepedia.org↗ peptidepedia.org
  • Lightheadedness post-injectionMild 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ peptidepedia.org
  • Moderate appetite stimulationMild 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ peptidepedia.org
  • Flushing and warmthMild 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ peptidepedia.org
  • Transient drowsinessMild 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ peptidepedia.org
  • Intense appetite stimulationMild 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ peptidepedia.org
  • Transient flushing and dizzinessMild 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ peptidepedia.org
  • Moderate appetite increaseMild 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ peptidepedia.org
  • Mild water retentionMildReported in 3 sources 60/100Rated 60/100Source typeSpecialist communityIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ peptidepedia.org↗ holisticnootropics.com↗ peptide-db.com
  • LightheadednessMild 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ peptidepedia.org
  • Increased hunger and gastric emptying (GHRP-2/GHRP-6)Mild 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ excelmale.com
  • Elevated prolactin and cortisol (GHRP-2/GHRP-6)Moderate 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ excelmale.com

Reported in research and community sources — not exhaustive. Discontinue use and consult a healthcare professional if side effects occur.

Get GHRP-2

Compare research-grade suppliers with third-party COAs and published purity data. For in-vitro and laboratory research use only — not for human consumption, diagnosis, or treatment.

Shop GHRP-2
Code ths10 applied at checkout
Technical Details (sequence & mechanism — click to expand)

Mechanism of Action

GHRP-2 (pralmorelin) is a synthetic hexapeptide agonist of the ghrelin receptor (GHSR-1a) on pituitary somatotropes, stimulating potent endogenous GH release (peak GH 30-100 ng/mL). It also increases appetite, mimicking ghrelin. Used as a diagnostic for GH deficiency; not approved therapeutically in the US.

Evidence

Research Citations (6)

Every claim above traces back to a source you can check — here are 6 of them.

  • Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men

    Review2010 Key study 82/100Rated 82/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Pralmorelin: GHRP 2, GPA 748, growth hormone-releasing peptide 2, KP-102 D, KP-102 LN, KP-102D, KP-102LN.

    Review2004 80/100Rated 80/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • General pharmacology of KP-102 (GHRP-2), a potent growth hormone-releasing peptide.

    2004 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • PubChem - Compound - Pralmorelin

    95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • ACTH releasing activity of KP-102 (GHRP-2) in rats is mediated mainly by release of CRF

    95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Determinants of GH-releasing hormone and GH-releasing peptide synergy in men

    95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source

Timeline

History & Milestones

Key moments in GHRP-2’s research and regulatory timeline — sourced and dated.

  1. GHRP-2 (pralmorelin): diagnostic agent for GH deficiencyPublicationJan 1, 2004
    Related:GHRP-2
    80/100Rated 80/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source

News

Latest on GHRP-2

Dated, sourced reporting that mentions GHRP-2.

Regulatory

Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks

FDA's running list of bulk drug substances that present significant safety risks in compounding names GHRP-2, GHRP-6, ipamorelin acetate, CJC-1295 and AOD-9604. GHRP-2 and GHRP-6 were added to the 503B risk list on September 29, 2023 over immunogenicity concerns, and FDA notes serious adverse events for CJC-1295 (increased heart rate, systemic vasodilatory reactions). The list confirms these peptides are treated by FDA as unsafe-for-compounding substances.

90/100Rated 90/100Source typeRegulator or clinical registryIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →Read →
Regulatory

Tailor Made Compounding LLC

FDA warned Tailor Made Compounding LLC (Nicholasville, KY) after a 2018 inspection found it compounded drug products with bulk substances ineligible for 503A exemptions. The letter explicitly lists the compounded substances: Follistatin, GHRP-2, GHRP-6, AOD 9604, BPC 157, Bremelanotide (PT-141), Cerebrolysin, DSIP, Epitalon, GHK-Cu, Ipamorelin, LL-37, Melanotan II, Selank, Semax, and CJC 1295, among others. The firm was cited for insanitary aseptic processing (adulteration), unapproved new drugs, and misbranding, and removed GHRP-2 and GHRP-6 from its formulary in response.

90/100Rated 90/100Source typeRegulator or clinical registryIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →Read →

Wondering how GHRP-2 pricing compares across suppliers? Our original market data shows the full picture.

See the State of the Peptide Market 2026 →

Related on The Health Stacks

Free: The Peptide Stack Cheat-Sheet

The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.

No spam. Unsubscribe anytime.